Recombinant Subunit Vaccine

Clover Biopharmaceuticals is producing a recombinant subunit vaccine based on the trimeric S-protein of COVID-19. The oral recombinant vaccine is being expanded by Vaxart in tablet formulation, using its propriety oral vaccine platform.